MPCi

Activity from announced rounds

All recorded activity

MPCi is the China-focused investment manager identified by its own site and by Tripo, Aureka and Excalipoint announcements.

Recorded funding activity

Tripo develops generative 3D tools. Aureka builds biological models and discovery infrastructure, while Excalipoint develops T-cell therapies. The manager remains distinct from US Matrix and independently operated regional firms.

Sources
Rounds participated in
10
Confirmed lead rounds
5
2 roles undisclosed
New companies
8
First participation on record · 2 follow-on
Funding in participating rounds
$327.7M
3 disclosed · full round size, not this investor’s share

By stage

Seed6
Series B3
Series A1

By primary sector

Hardware5
AI2
Biotech2
Industrial tech1

By country

China9
United States1

Rounds

10 in all activity
PollyPolymer

Develops polymer materials, ultrafast 3D printers and manufacturing software for production-scale parts.

UndisclosedSeries B+
Lead
XILECT

Robot-computing chip developer founded by MetaX and UBTECH, combining GPU architecture with robotics engineering.

Lead
Sand.ai

Sand.ai develops video-generation foundation models and AI tools for creating audiovisual content.

$200MSeries A+
Participant
Tripo AI

Tripo AI builds generative 3D models and a creator workspace for consumers, developers, and enterprise teams.

~$445MSeries B
Lead
Aureka Biotechnologies

Builds biological foundation models and closed-loop infrastructure for drug discovery

$100MSeries B
Role not disclosed
HOUMO.AI

Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.

Lead
HOUMO.AI

Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.

Participant
HOUMO.AI

Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.

Participant